Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
WXrkvpZn6GYzT2pg
Listen
